Manufacturer of pharmaceutical-grade CBD products to meet global Cannabinoid demand
Studies have demonstrated CBD’s proficiency to treat inflammation with the ability to remedy a number of physical and mental illnesses. Compounds with anti-inflammatory properties are highly prized in both wellness and medical markets, and CBD has the added benefits of antibacterial and antiviral attributes. With the popularity of tinctures, topicals and capsules promoting increased consumer accessibility and adoption, the global CBD market is expected to surpass $13 billion in revenue by 2028. The EU cosmetic ingredient database determined that cannabinoids can be used in cleansers and conditioners, with hemp-based CBD oil particularly revered as it rejuvenates damaged skin.
Cannabidiol, or CBD, as it's better known, was once only a concern of the most tiresome of stoners. Now you can find it in tampons, face creams, ice creams, hummus, water, and at Tesco. It's a multibillion-dollar industry: the UK's CBD market alone has been forecast to reach $1.2 billion by 2025.
Vantage Hemp Co. is pleased to announce its new partnership with Medcan Australia (Medcan) and expansion into the Australian CBD market through the distribution of their pharmaceutical grade CBD extracts.
Industry-leading cannabinoid extractor enhances offerings with white label solutions
Following the groundbreaking success of Vantage Hemp Co. in the cannabinoid industry, the company has announced the expansion of its contract manufacturing services to include a white labeling program. The only North American hemp processor with both ICH Q7 and WHO Good Manufacturing Practices (GMP) certified facilities, Vantage Hemp is one of the highest accredited cannabinoid extractors in the world, which enables Vantage Hemp and its partners to export pharmaceutical-grade CBD products internationally.
Colorado-based CBD-hemp extraction company Vantage Hemp Co. announced today it is in the process of achieving compliance with European novel food regulations regarding the distribution of pharmaceutical grade CBD extracts.